Effects of single and repeated in vitro exposure of three forms of parabens, methyl-, butyl-And propylparabens on the proliferation and estradiol secretion in MCF-7 and MCF-10A cells

Pharmacological Reports

Volumn 65, Issue 2, 2013, Pages 484-493

  Wróbel, Anna ^a   Gregoraszczuk, Ewa L ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Breast cancer cells line; Estradiol secretion; Parabens; Proliferation

Indexed keywords

AROMATASE; BUTYL PARABEN; ESTRADIOL; METHYL PARABEN; PROPYL PARABEN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL ACTIVITY; CELL LINE; CELL PROLIFERATION; CELL STRAIN MCF 10A; CELL STRAIN MCF 7; CONTROLLED STUDY; CORRELATION ANALYSIS; CYP19A1 GENE; ENZYME ACTIVITY; GENE; GENE SEQUENCE; HORMONE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

EID: 84879326584     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/s1734-1140(13)71024-7     Document Type: Article

References (31)

1. Benbrahim-Tallaa L, Tokar EJ, Diwan BA, Dill AL, Coppin JF, Waalkes MP: Cadmium malignantly transforms normal human breast epithelial cells into a basallike phenotype. Environ Health Perspect, 2009, 117, 1847-1852.
2. Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W et al.: The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol Sci, 2000, 54, 138-153.
3. Byford JR, Shaw LE, Drew MG, Pope GS, Sauer MJ, Darbre PD: Oestrogenic activity of parabens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol, 2002, 80, 49-60.
4. Calabrese EJ, Baldwin LA: The hormetic dose-response model is more common than the threshold model in toxicology. Toxicol Sci, 2003, 71, 246-250.
5. Darbre PD: Environmental oestrogens, cosmetics and breast cancer. Best Pract Res Clin Endocrinol Metab, 2006, 20, 121-143.
6. Darbre PD: Underarm cosmetics and breast cancer. J Appl Toxicol, 2003, 23, 89-95.
7. Darbre PD, Aljarrah A, Miller WR,Coldham NG, Sauer MJ, Pope GS: Concentrations of parabens in human breast tumors. J. Appl Toxicol, 2004, 24, 5-13.
8. Darbre PD, Byford JR, Shaw LE, Horton RA, Pope GS, Sauer MJ: Oestrogenic activity of isobutylparaben in vitro and in vivo. J Appl Toxicol, 2002, 22, 219-226.
9. Duft M, Schulte-Oehlmann U, Weltje L, Tillmann M, Oehlmann J: Stimulated embryo production as a parameter of estrogenic exposure via sediments in the freshwater mudsnail Potamopyrgus antipodarum. Aquat Toxicol, 2003, 64, 437-449.
10. Elder RL: The cosmetic ingredient review -A safety evaluation program. J Am Acad Dermatol, 1984, 11, 1168-1174.
11. Ellsworth DL, Ellsworth RE, Liebman MN, Hooke JA, Shriver CD: Genomic instability in histologically normal breast tissues: implications for carcinogenesis. Lancet Oncol, 2004, 5, 753-758.
12. Ellsworth DL, Ellsworth RE, Love B, Deyarmin B, Lubert SM, Mittal V, Hooke JA, Shriver CD: Outer breast quadrants demonstrate increased levels of genomic instability. Ann Surg Oncol, 2004, 11, 861-868.
13. Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS et al.: Structure-Activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem Res Toxicol, 2001, 14, 280-294.
14. Hawkins RA, Tesdale AL, Killen ME, Jack WJ, Chetty U, Dixon JM, Hulme MJ et al.: Prospective evaluation of prognostic factors in operable breast cancer. Br J Cancer, 1996, 74, 1469-1478.
15. Hevir N, Trošt N, Debeljak N, Lanišnik Ri.ner T: Expression of estrogen and progesterone receptors and estrogen metabolizing enzymes in different breast cancer cell lines. Chem Biol Interact, 2011, 191, 206-216.
16. Jobling S, Casey D, Rodgers-Gray T, Oehlmann J, Schulte-Oehlmann U, Pawlowski S, Braunbeck T et al.: Comparative responses of mollusks and fish to environmental estrogens and an estrogenic effluent. Aquat Toxicol, 2004, 66, 207-222.
17. Lee SH, Kim HJ, Kang HJ, Lee YJ, Nam HS, Bae I: Reactive oxygen species generated by 17b-estradiol play a role in the up-regulation of GPX4 protein in MCF-7 breast cancer cells. J Breast Cancer, 2009, 12, 134-141.
18. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT) Method. Methods, 2001, 25, 402-408.
19. Lonning PE: Endocrinology and treatment of breast cancer. Clin Endocrinol Metab, 2004, 18, 1-130.
20. McGrath KG: An earlier age of breast cancer diagnosis related to more frequent use of antiperspirants/deodorants and underarm shaving. Eur J Cancer Prev, 2003, 12, 479-485.
21. Oehlmann J, Schulte-Oehlmann U, Tillmann M, Markert B: Effects of endocrine disruptors on prosobranch snails (Mollusca: Gastropoda) in the laboratory. Part I: Bisphenol A and octylphenol as xeno-estrogens. Ecotoxicology, 2000, 9, 383-397.
22. Oishi S: Effects of butylparaben on the male reproductive system in rats. Toxicol Ind Health, 2001, 17, 31-39.
23. Okubo T, Yokoyama Y, Kano K, Kano I: ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERa and PR. Food Chem Toxicol, 2001, 39, 1225-1232.
24. Pedram A, Razandi M, Wallace DC, Levin ER: Functional estrogen receptors in mitochondria of breast cancer cells. Mol Biol Cell, 2006, 17, 2125-2137.
25. Pugazhendhi D, Pope GS, Darber PD: Oestrogenic activity of p-hydroxybenzoic acid (common metabolite of paraben esters) and methylparaben in human breast cancer cell lines. J Appl Toxicol, 2005, 25, 301-309.
26. Routledge EJ, Parker J, Odum J, Ashby J, Sumpter JP: Some alkyl hydroxyl-benzoate preservatives (parabens) are estrogenic. Toxicol Appl Pharmacol, 1998, 153, 12-19.
27. Vanparys C, Maras M, Lenjou M, Robbens J, Van Bockstaele D, Blust R, De Coen W: Flow cytometric cell cycle analysis allows for rapid screening of estrogenicity in MCF-7 breast cancer cells. Toxicol In Vitro, 2006, 20, 1238-1248.
28. van Duursen MB, Sanderson JT, van der Bruggen M, van der Linden J, van den Berg M: Effects of several dioxin-like compounds on estrogen metabolism in the malignant MCF-7 and nontumorigenic MCF-10A human mammary epithelial cell lines. Toxicol Appl Pharmacol, 2003, 190, 241-250.
29. van Meeuwen JA, van Son O, Piersma AH, de Jong PC, van den Berg M: Aromatase inhibiting and combined estrogenic effects of parabens and estrogenic effects of other additives in cosmetics. Toxicol Appl Pharmacol, 2008, 230, 372-382.
30. Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, vom Saal FS: Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect, 2003, 111, 994-1006.
31. Zientek-Targosz H, Kunnev D, Hawthorn L, Venkov M, Matsui S, Cheney RT, Ionov Y: Transformation of MCF-10A cells by random mutagenesis with frameshift mutagen ICR191: a model for identifying candidate breast-tumor suppressors. Mol Cancer, 2008, 5, 7-51.